These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16445652)

  • 21. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Squamous cell carcinoma in situ of the vagina and cervix after intrauterine DES exposure.
    Veridiano NP; Tancer ML; Weiner EA
    Obstet Gynecol; 1978 Jul; 52(1 Suppl):30S-33S. PubMed ID: 683639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary non-clear-cell adenocarcinoma of the vagina in a diethylstilbestrol exposed woman.
    Patel SA; Sunde J
    Mil Med; 2014 Apr; 179(4):e461-2. PubMed ID: 24690973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    J Med Assoc State Ala; 1977 Mar; 46(9):39-41. PubMed ID: 845523
    [No Abstract]   [Full Text] [Related]  

  • 26. Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero.
    Mittendorf R
    Teratology; 1995 Jun; 51(6):435-45. PubMed ID: 7502243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DES-related female genital changes.
    Holt LH; Herbst AL
    Semin Oncol; 1982 Sep; 9(3):341-8. PubMed ID: 7134996
    [No Abstract]   [Full Text] [Related]  

  • 28. Concurrent primaries of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma in a 39-year old woman with in utero diethylstilbestrol exposure.
    Keller C; Nanda R; Shannon RL; Amit A; Kaplan AL
    Int J Gynecol Cancer; 2001; 11(3):247-50. PubMed ID: 11437935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
    Hall WB; Detterbeck FC; Livasy CA; Fowler WC
    Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
    Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
    J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diethylstilbestrol: Potential health risks for women exposed in utero and their offspring.
    Conlon JL
    JAAPA; 2017 Feb; 30(2):49-52. PubMed ID: 28098674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of cervical and vaginal squamous cell neoplasia as a late consequence of in utero exposure to diethylstilbestrol.
    Bornstein J; Adam E; Adler-Storthz K; Kaufman RH
    Obstet Gynecol Surv; 1988 Jan; 43(1):15-21. PubMed ID: 2829071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. During development, 17alpha-estradiol is a potent estrogen and carcinogen.
    Hajek RA; Robertson AD; Johnston DA; Van NT; Tcholakian RK; Wagner LA; Conti CJ; Meistrich ML; Contreras N; Edwards CL; Jones LA
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):577-81. PubMed ID: 9167998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
    Melnick S; Cole P; Anderson D; Herbst A
    N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic.
    Piver MS; Lele SB; Baker TR; Sandecki A
    Cancer Detect Prev; 1988; 11(3-6):197-202. PubMed ID: 3390844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project.
    Robboy SJ; Noller KL; O'Brien P; Kaufman RH; Townsend D; Barnes AB; Gundersen J; Lawrence WD; Bergstrahl E; McGorray S
    JAMA; 1984 Dec; 252(21):2979-83. PubMed ID: 6502858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bcl-2 protein expression associated with resistance to apoptosis in clear cell adenocarcinomas of the vagina and cervix expressing wild-type p53.
    Waggoner SE; Baunoch DA; Anderson SA; Leigh F; Zagaja VG
    Ann Surg Oncol; 1998 Sep; 5(6):544-7. PubMed ID: 9754764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
    Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
    Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
    Herbst AL; Scully RE; Robboy SJ
    J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.